Metraipolis › archive › dc_714e52c30bec
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial — Europe PMC PMID:41698954
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41698954
- DOI
- 10.1038/s41467-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T18:08:36.611Z
- SHA-256 of the archived text
138692f2e7d662d873eca70f35017287a854d210af8d0b4c428f3998a2948040- Stable URL of this page
https://metraipolis.com/documento/dc_714e52c30bec
How to cite
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial — Europe PMC PMID:41698954 — Europe PMC (en), https://europepmc.org/article/MED/41698954 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_714e52c30bec (Metraipolis archive dc_714e52c30bec, sha256 138692f2e7d662d873eca70f35017287a854d210af8d0b4c428f3998a2948040)
BibTeX
@misc{dc714e52c30bec,
title = {LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial — Europe PMC PMID:41698954},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41698954},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_714e52c30bec; sha256 138692f2e7d662d873eca70f35017287a854d210af8d0b4c428f3998a2948040},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41698954. Agents can read the archived copy with the MCP tool read_document.